Literature DB >> 35348110

Successful Use of Glycoprotein IIb/IIIa Inhibitor Involving Severely Ill COVID-19 Patient.

Patrick Joseph Merrill1, R Mark Bradburne2.   

Abstract

This case report describes a successful outcome involving a patient with severe COVID-19 viral pneumonia utilizing a novel therapeutic approach with the glycoprotein IIb/IIIa inhibitor, eptifibatide.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 35348110      PMCID： PMC8784086          DOI： 10.7812/TPP/21.125

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


  5 in total

1.  Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.

Authors:  Christophe Guervilly; Stephane Burtey; Florence Sabatier; Raphaël Cauchois; Guillaume Lano; Evelyne Abdili; Florence Daviet; Laurent Arnaud; Philippe Brunet; Sami Hraiech; Noémie Jourde-Chiche; Marie Koubi; Romaric Lacroix; Léa Pietri; Yaël Berda; Thomas Robert; Clara Degioanni; Mélanie Velier; Laurent Papazian; Gilles Kaplanski; Françoise Dignat-George
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

Review 2.  Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.

Authors:  Seena Tabibi; Tara Tabibi; Rosalynn R Z Conic; Nassim Banisaeed; Michael B Streiff
Journal:  J Intensive Care Med       Date:  2020-07-15       Impact factor: 3.510

3.  Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.

Authors:  Xiaoyan Liu; Zhe Li; Shuai Liu; Jing Sun; Zhanghua Chen; Min Jiang; Qingling Zhang; Yinghua Wei; Xin Wang; Yi-You Huang; Yinyi Shi; Yanhui Xu; Huifang Xian; Fan Bai; Changxing Ou; Bei Xiong; Andrew M Lew; Jun Cui; Rongli Fang; Hui Huang; Jincun Zhao; Xuechuan Hong; Yuxia Zhang; Fuling Zhou; Hai-Bin Luo
Journal:  Acta Pharm Sin B       Date:  2020-04-20       Impact factor: 11.413

Review 4.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.

Authors:  Behnood Bikdeli; Mahesh V Madhavan; David Jimenez; Taylor Chuich; Isaac Dreyfus; Elissa Driggin; Caroline Der Nigoghossian; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Joseph A Caprini; Alfonso J Tafur; John R Burton; Dominic P Francese; Elizabeth Y Wang; Anna Falanga; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; P Gabriel Steg; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2020-04-17       Impact factor: 24.094

5.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

Authors:  I Hamming; W Timens; M L C Bulthuis; A T Lely; G J Navis; H van Goor
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.